LEADER 04205oam  2201009 a 450 
001 9910816151003321
005 20250113051854.0
010   $a9781118799529
010   $a1118799526
010   $a9781118799536
010   $a1118799534
035   $a(CKB)2670000000617960
035   $a(EBL)1985785
035   $a(SSID)ssj0001515602
035   $a(PQKBManifestationID)12550793
035   $a(PQKBTitleCode)TC0001515602
035   $a(PQKBWorkID)11482716
035   $a(PQKB)11758313
035   $a(DLC)  2015019440
035   $a(Au-PeEL)EBL4038783
035   $a(CaPaEBR)ebr11112583
035   $a(CaONFJC)MIL788215
035   $a(PPN)190377992
035   $a(OCoLC)909112553
035   $a(UkLoHST)3630
035   $a(MiAaPQ)EBC4038783
035   $a(UkLoHST)HST4519
035   $a(MiAaPQ)EBC1985785
035   $a(EXLCZ)992670000000617960
071 50$a4519$bHenry Stewart Talks
100   $a20171218d2017      uy         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPulmonary drug delivery /$fAnthony J. Hickey
210   $aLondon $cHenry Stewart Talks$d2017
215   $a1 online resource (383 pages)
225 1 $aAdvances in asthma : new mechanisms, management strategies and treatments,$x2056-452X
225 1 $aDrug delivery,$x2056-452X
300   $aAnimated audio-visual presentation with synchronized narration.
300   $aTitle from title frames.
311 08$a9781118799505 
311 08$a111879950X 
311 08$a9781118799543 
311 08$a1118799542 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aContents: Pulmonary drug delivery -- Therapeutic targets -- Drug categories -- Lung deposition and clearance -- Inhaled drug products -- Mechanism of droplet formation pMDIs -- In vitro tests -- In vivo considerations.
330   $aDrug therapy via inhalation route is at the cutting edge of modern drug delivery research. There has been significant progress on the understanding of drug therapy via inhalation products. However, there are still problems associated with their formulation design, including the interaction between the active pharmaceutical ingredient(s) (APIs), excipients and devices. This book seeks to cover some of the most pertinent issues and challenges of such formulation design associated with industrial production and desirable clinical outcome.   The chapter topics have been selected with
410  0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pAdvances in asthma.
410  0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pDrug delivery.
606   $aAerosol therapy
606   $aAntiasthmatic agents
606   $aDrug delivery systems
606   $aLungs$xDiseases$xTreatment
606   $aPharmaceutical technology
606   $aAdministration, Inhalation
606   $aAerosols$xtherapeutic use
606   $aAnti-Asthmatic Agents$xadministration & dosage
606   $aDrug Delivery Systems
606   $aLung Diseases$xdrug therapy
606   $aNebulizers and Vaporizers
606   $aPharmaceutical Preparations$xadministration & dosage
606   $aPulmonary Ventilation$xphysiology
615  0$aAerosol therapy.
615  0$aAntiasthmatic agents.
615  0$aDrug delivery systems.
615  0$aLungs$xDiseases$xTreatment.
615  0$aPharmaceutical technology.
615  2$aAdministration, Inhalation.
615  2$aAerosols$xtherapeutic use.
615  2$aAnti-Asthmatic Agents$xadministration & dosage.
615  2$aDrug Delivery Systems.
615  2$aLung Diseases$xdrug therapy.
615  2$aNebulizers and Vaporizers.
615  2$aPharmaceutical Preparations$xadministration & dosage.
615  2$aPulmonary Ventilation$xphysiology.
676   $a615.1
700   $aHickey$b Anthony J.$f1955-$4spk$0554307
712 02$aHenry Stewart Talks (Firm)
801  0$bUkLoHST
801  1$bUkLoHST
906   $aBOOK
912   $a9910816151003321
996   $aPulmonary drug delivery$94136687
997   $aUNINA